Search research articles
Contact Us
Filters
Showing results (61-70 of 164) with videos related to
Page
of 17
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 29, 2013
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass
Stephen L Chan, Frankie Mo, Philip J Johnson, et al.
The Oncologist
|
May 27, 2018
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer
Stephen L Chan, Anthony W H Chan, Frankie Mo, et al.
Gastroenterology
|
September 28, 2019
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Xiaofan Ding, Mian He, Anthony W H Chan, et al.
Gastroenterology
|
May 20, 2020
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Xiaofan Ding, Mian He, Anthony W H Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy
Stephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Diseases (Basel, Switzerland)
|
December 24, 2025
Clinical Implications of Upregulated <i>RSAD2</i> Gene Expression in Hepatocellular Carcinoma
Leung Li, Nelson L S Tang, Stephen L Chan, et al.
JHEP Reports : Innovation in Hepatology
|
April 15, 2024
A phase Ib/II trial of capmatinib plus spartalizumab <i>vs.</i> spartalizumab alone in patients with pretreated hepatocellular carcinoma
Armando Santoro, Eric Assenat, Thomas Yau, et al.
Cancer
|
June 23, 2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma
Stephen L Chan, Winnie Yeo, Frankie Mo, et al.
British Journal of Cancer
|
November 11, 2017
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Jane Margetts, Laura F Ogle, Stephen L Chan, et al.
Disease Markers
|
March 5, 2015
Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma
Anthony W H Chan, Stephen L Chan, Frankie K F Mo, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 164) with videos related to
Sort By:
Page
of 17
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 29, 2013
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass
Stephen L Chan, Frankie Mo, Philip J Johnson, et al.
The Oncologist
|
May 27, 2018
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer
Stephen L Chan, Anthony W H Chan, Frankie Mo, et al.
Gastroenterology
|
September 28, 2019
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Xiaofan Ding, Mian He, Anthony W H Chan, et al.
Gastroenterology
|
May 20, 2020
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Xiaofan Ding, Mian He, Anthony W H Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy
Stephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Diseases (Basel, Switzerland)
|
December 24, 2025
Clinical Implications of Upregulated <i>RSAD2</i> Gene Expression in Hepatocellular Carcinoma
Leung Li, Nelson L S Tang, Stephen L Chan, et al.
JHEP Reports : Innovation in Hepatology
|
April 15, 2024
A phase Ib/II trial of capmatinib plus spartalizumab <i>vs.</i> spartalizumab alone in patients with pretreated hepatocellular carcinoma
Armando Santoro, Eric Assenat, Thomas Yau, et al.
Cancer
|
June 23, 2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma
Stephen L Chan, Winnie Yeo, Frankie Mo, et al.
British Journal of Cancer
|
November 11, 2017
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Jane Margetts, Laura F Ogle, Stephen L Chan, et al.
Disease Markers
|
March 5, 2015
Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma
Anthony W H Chan, Stephen L Chan, Frankie K F Mo, et al.
Page
of 17